Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancerJ J Grau, J Estapé, J Fuster, et al.
Free Radical Biology & Medicine|October 9, 1999
Thyroid status modulates glycoxidative and lipoxidative modification of tissue proteinsR Pamplona, M Portero-Otín, C Ruiz, et al.
Investigational New Drugs|May 23, 2012
A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancerC Gómez-Martín, R Salazar, C Montagut, et al.
ESMO Open|June 12, 2026
Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitusJ B Aragon-Ching, S Gupta, P Grivas, et al.
Tumori|November 1, 1996
Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI)A Ribas, J Bellmunt, J Albanell, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 31, 2002
Protein oxidative stress in dialysis patientsTeresa Doñate, Alba Herreros, Ester Martinez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)J M Buesa, A López-Pousa, J Martín, et al.
British Journal of Cancer|December 24, 2014
Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patientsA Orsola, L Werner, I de Torres, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinomaJ Bellmunt, S A Mullane, L Werner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2011
Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activityJ Bellmunt, J L González-Larriba, C Prior, et al.
Pageof 13